Ignite Creation Date:
2024-10-25 @ 7:54 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06582940
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-28
Brief Title:
Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain Metastasis
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain Metastasis
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to explore the safety and efficacy of eliminating the planning target volume PTV margins based on MRI-guided adaptive stereotactic radiotherapy for non-small cell lung cancer NSCLC patients with brain metastasis
Detailed Description:
This study aims to explore the safety and efficacy of eliminating the planning target volume PTV margins based on MRI-guided adaptive stereotactic radiotherapy for NSCLC patients with brain metastasis In this study patients will be randomly assigned in a 11 ratio to the study group or the control group Patients in the study group will receive MRI-guided adaptive stereotactic radiotherapy SRT without PTV expansion margin while patients in the control group will receive CT-guided conventional standard SRT with PTV expansion margin After the completion of treatment patients will be followed up regularly to assess safety and efficacy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None